Web Results

Celgene

en.wikipedia.org/wiki/Celgene

Celgene Corporation is an American biotechnology company that manufactures drug therapies ... Celgene also receives royalties from Novartis Pharma AG on sales of the entire Ritalin family of drugs, ...

Celgene Gets Claims Trimmed From Andrulis Drug Patent Suit ...

www.law360.com/articles/527451/celgene-gets-claims-trimmed-from-andrulis-drug-patent-suit

Apr 11, 2014 ... The case is Andrulis Pharmaceuticals Corp. v. Celgene Corp., case number 1:13- cv-01644, in the U.S. District Court for the District of Delaware.

Andrulis Pharmaceuticals Corp. v. Celgene Corp., No. 1 ... - Justia Law

law.justia.com/cases/federal/district-courts/delaware/dedce/1:2013cv01644/53249/149/

Jun 26, 2015 ... Andrulis Pharmaceuticals Corp. v. Celgene Corp., No. 1:2013cv01644 - Document 149 (D. Del. 2015) case opinion from the District of ...

District Court Finds Enhanced Patent Indefiniteness - PharmaPatents

www.pharmapatentsblog.com/2015/08/04/district-court-finds-enhanced-patent-indefiniteness/

Aug 4, 2015 ... I don't usually write about district court decisions, but the patent indefiniteness ruling in Andrulis Pharmaceuticals Corp. v. Celgene Corp.

An Update On Appellate Review Of Indefiniteness - Covington ...

www.cov.com/-/media/files/corporate/publications/2016/05/an_update_on_appellate_review_of_indefiniteness.pdf

May 12, 2016 ... ... and/or some combination of the two.”[10]. Andrulis Pharmaceuticals Corp. v. Celgene Corp. is another example of this type of indefiniteness.

Posts in Motion to Strike/Preclude: Delaware Patent Litigation Report

www.morrisjames.com/blogs-Delaware-Patent-Litigation-Report,category,motion-to-strikepreclude

Apr 13, 2016 ... St. Clair Intellectual Property Consultants, Inc. v. Toshiba .... Celgene Corporation , et al. v. Fresenius Kabi .... Andrulis Pharmaceuticals Corp. v.

Judge Andrews finds terms indefinite at claim construction ...

www.delawareiplaw.com/2015/07/judge-andrews-finds-terms-indefinite-at-claim-construction.html

Jul 1, 2015 ... In Andrulis Pharmaceuticals Corp. v. Celgene Corp., C.A. No. 13-1644-RGA (D. Del. June 26, 2015), Judge Richard G. Andrews construed ...

Patent US7230012 - Pharmaceutical compositions and dosage ...

www.google.com/patents/US7230012

Jun 12, 2007 ... Pharmaceutical compositions and single unit dosage forms of thalidomide and ... such as, but not limited to, leprosy, chronic graft-vs-host disease, rheumatoid arthritis, sarcoidosis, ... Original Assignee, Celgene Corporation ...... US5405855, Dec 23, 1993, Apr 11, 1995, Andrulis Pharmaceuticals Corp.

Patent Docs: Court Report

www.patentdocs.org/2013/10/court.html

Oct 6, 2013 ... Andrulis Pharmaceuticals Corp. v. Celgene Corp. 1:13-cv-01644; filed October 2, 2013 in the District Court of Delaware. Infringement of U.S. ...

5 - Federal Circuit Court Decisions | Finnegan

www.finnegan.com/zh-CHS/publications/federalcircuit/FederalCircuitCourtLanding.aspx?viewallcases=View all cases&KeywordPhrase=&p=5

LendingTree, LLC v. Zillow, Inc. 14-1435 14-1531 ... Andrulis Pharmaceuticals Corporation v. Celgene Corporation [rule 36 judgment]. 15-1962. Decision icon ...

More Info

Andrulis v. Celgene: District Court Dismisses Undivided Direct ...

patentlaw.jmbm.com

Apr 21, 2014 ... Plaintiff Andrulis Pharmaceuticals Corp. ("Andrulis") filed a patent infringement action against Celgene Corporation ("Celgene") alleging direct, ...

RULE 36 JUDGMENT - US Court of Appeals for the Federal Circuit

www.cafc.uscourts.gov

Jul 14, 2016 ... ANDRULIS PHARMACEUTICALS CORPORATION,. Plaintiff-Appellant v. CELGENE CORPORATION,. Defendant-Appellee ...

View Complaint - RPX Search

search.rpxcorp.com

Oct 2, 2013 ... For its Complaint, Andrulis Pharmaceuticals Corp., by and through its attorneys, ... (“Celgene”) is a Delaware corporation with its principal.